
Tirzepatide Pre-filled Pen 10mg Weight Loss
Double action, réglage au clic.
Tirzepatide without a single step of preparation. A dual GIP and GLP-1 agonist, delivered as a ready-to-use pen: the solution is already in the cartridge, the dose is set on a dial. No reconstitution, no bacteriostatic water, no syringe to hunt down at a pharmacy. 10 mg in 3 ml, which is four weeks at the documented starting step. Four needles are included: you inject the day it arrives, no pharmacy run. For research use.
-10 % for life on each cyclePause, skip or cancel in 1 clickNo commitment, no hidden fees
One sealed vial of Tirzepatide Pre-filled Pen 10mg, lyophilised, without individual labelling.
Bacteriostatic water for reconstitution and 1 ml precision syringes graduated in 100 units, sold separately. The vial alone cannot be used as is.
Don't forget the essentials
Tirzepatide is a dual GIP and GLP-1 receptor agonist, the most studied molecule of its generation after semaglutide. In a pre-filled pen it loses what puts people off research protocols: reconstitution, volume calculation and drawing up with a syringe. The solution is ready inside the cartridge and the dose is set on a dial.
01Mechanism of action
Tirzepatide activates two incretin receptors at once, GIP and GLP-1. This dual action sets it apart from GLP-1-only agonists and accounts for the scale of the metabolic effects reported in the literature. Retatrutide adds a third axis, the glucagon receptor. All three belong to the same family and follow the same step-up logic.
Similar peptides
Against the 10 mg Tirzepatide vial, the pen removes three steps and two purchases: no bacteriostatic water, no syringe, no concentration maths. The vial remains the choice for anyone who wants to set their own concentration or split it differently. Against Retatrutide in pen form, Tirzepatide acts on two receptors instead of three and is dosed in higher milligram steps: they are two distinct molecules, not two strengths of the same product.
